MPM Event Schedule

116th  Missouri Osteopathic Annual Convention
May, 1-2 , 2014
Chateau on the Lake, Branson MO

MGMA  Spring Conference
May 4-6, 2014
Tan-Tar-A Resort, Osage Beach, MO

Missouri  American College of Surgeons
May 30-June 1, 2014
Lodge of the Four Seasons

ACOG Annual Meeting
June 13-14, 2014
Big Cedar Lodge, Branson , MO

Now Available - The 2013 MPM Annual Report

Click here to download yours!

MPM News

ST. LOUIS COUNTY COURT DISMISSES KEANE INSURANCE ALLEGATIONS AGAINST MISSOURI PROFESSIONALS MUTUAL

…Read Full Article on STLToday

We are happy to report that MPM yet again is Missouri’s 1# Medical Professional Liability Insurance Company

TOP 3 MISSOURI MEDICAL PROFESSIONAL LIABILITY INSURANCE COMPANIES

2013 Missouri Marketshare
1. MPM / MPMKS 12.87%
2. Medical Protective Co. 12.72%
3. Medical Liability Alliance 12.37%

 

Four Missouri Doctors Elected to Missouri Professionals Mutual Board

Frederick B. Lintecum, M.D., Walter R. Peters, Jr., M.D., Raymond August Ritter, III, M.D., and David L. Weinstein, M.D. will help MPM continue to re-empower Missouri physicians… Read More

 

PHYSICIAN SPOTLIGHT: David Weinstein, MD

St. Louis OB/GYN David Weinstein, MD, opts not to bemoan the frustrations physicians often face in their practices. Rather, he works to fix them… Read More

 

Jim Reinert Honored for Most Defense Verdicts in 2013.

Jim Reinert will be honored for obtaining the most defense verdicts of any attorney in Missouri in 2013.  Read More

Daily Industry News

  • FDA Panel Says No to Shock Therapy Device

    (MedPage Today) — GAITHERSBURG, Md. — Members of an FDA advisory panel said Thursday that the agency should ban the use of electrical stimulation devices for aversive conditioning in patients with self-injurious or aggressive behavior.

  • Vax for Kids Saves Lives and $$$ (CME/CE)

    (MedPage Today) — A U.S. vaccination program that costs $4 billion a year has saved more than $1.6 trillion since it was inaugurated in 1994, the CDC said.

  • FDA: DNA Test Can Replace Pap Test

    WASHINGTON (MedPage Today) — The FDA has approved a molecular test for human papillomavirus DNA as a first-line, stand-alone screen for cervical cancer.